NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 213 filers reported holding NEVRO CORP in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $22,294,000 | -36.1% | 275,000 | -8.3% | 0.26% | -40.5% |
| Q3 2021 | $34,914,000 | +6745.9% | 300,000 | +8107.9% | 0.43% | +6071.4% |
| Q1 2021 | $510,000 | -74.9% | 3,655 | -68.9% | 0.01% | -75.9% |
| Q4 2020 | $2,035,000 | -85.6% | 11,755 | -90.1% | 0.03% | -86.5% |
| Q2 2020 | $14,156,000 | -34.3% | 118,491 | -56.1% | 0.22% | +11.4% |
| Q2 2018 | $21,545,000 | +734.4% | 269,816 | +621.4% | 0.19% | +819.0% |
| Q4 2017 | $2,582,000 | +181.0% | 37,400 | +324.6% | 0.02% | +133.3% |
| Q3 2016 | $919,000 | -69.9% | 8,808 | -78.7% | 0.01% | -69.0% |
| Q2 2016 | $3,051,000 | +56.6% | 41,367 | +19.5% | 0.03% | +61.1% |
| Q1 2016 | $1,948,000 | – | 34,617 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |